Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹32 Cr
Revenue (TTM)
₹33 Cr
Net Profit (TTM)
₹2 Cr
ROE
12.3 %
ROCE
10.3 %
P/E Ratio
16
P/B Ratio
1
Industry P/E
34.17
EV/EBITDA
14.1
Div. Yield
0 %
Debt to Equity
0.7
Book Value
₹38
EPS
₹4.7
Face value
10
Shares outstanding
8,582,400
CFO
₹-11.91 Cr
EBITDA
₹8.37 Cr
Net Profit
₹5.26 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
SUNREST
| 1.1 | -6.6 | -6.6 | -21.8 | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
SUNREST
| -19.3 | -18.4 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
SUNREST
|
37.5 | 32.2 | 33.4 | 2.0 | -- | 12.3 | 16 | 1.0 |
| 989.6 | 12,119.0 | 2,512.3 | 543.7 | 28.3 | 19.3 | 22.3 | 3.8 | |
| 357.4 | 6,190.1 | 1,053.1 | 293.6 | 32.3 | 24.6 | 21.1 | 4.8 | |
| 1,025.1 | 10,733.1 | 1,158.7 | 309.6 | 31.9 | 17.3 | 34.3 | 5.7 | |
| 1,547.6 | 29,354.2 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.7 | 5.9 | |
| 12,433.0 | 15,953.0 | 1,575.1 | 179.1 | 14.9 | 11.4 | 89.1 | 9.6 | |
| 1,921.2 | 3,180.4 | 673.7 | 202.6 | 17.6 | 19.4 | 15.7 | 5.5 | |
| 784.3 | 3,617.1 | 588.5 | 102.9 | 22.1 | 12.7 | 35.6 | 4.3 | |
| 615.1 | 6,946.9 | 502.0 | 138.7 | -- | 32.8 | 50.1 | 8.0 | |
| 158.0 | 4,151.0 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 6.2 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
2017
Chairman
Juhi Sawajani
Managing Director
Nikhilkumar Y Thakkar
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Sunrest Lifescience Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Sunrest Lifescience Ltd is ₹37.50 (NSE) as of 02-Apr-2026 15:24 IST. Sunrest Lifescience Ltd has given a return of -21.82% in the last 1 years.
The P/E ratio of Sunrest Lifescience Ltd is 16.05 times as on 01-Apr-2026, a 53 discount to its peers’ median range of 34.17 times.
The P/B ratio of Sunrest Lifescience Ltd is 1.03 times as on 01-Apr-2026, a 73 discount to its peers’ median range of 3.82 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
11.50
|
1.26
|
|
2024
|
116.07
|
1.65
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Sunrest Lifescience Ltd are Rs 54.43 and Rs 0.00 as of 03-Apr-2026.
Sunrest Lifescience Ltd has a market capitalisation of ₹ 32 Cr as on 01-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Sunrest Lifescience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.